Royal Bank of Canada
RY
Canadian Imperial Bank of Commerce
CM
The Toronto-Dominion Bank
TD
4
Bank of Nova Scotia
BNS
5
Bank of Montreal
BMO
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 136.04%100.02K | 5.58%67.42K | 92.34%-15.98K | -251.77%-345.95K | 26.74%-243.45K | -87.09%42.38K | 163.95%63.86K | -162.92%-208.74K | 145.82%227.94K | -445.98%-332.29K |
Net income from continuing operations | 309.20%68.12K | -0.34%-557.03K | -7.50%-781.87K | 8.10%-2.07M | 25.25%-757.53K | 64.61%-32.56K | -38.22%-555.14K | 2.79%-727.35K | 33.08%-2.26M | 54.32%-1.01M |
Operating gains losses | --0 | --0 | ---156 | 204.10%16.99K | --0 | ---23.87K | ---- | ---- | -533.98%-16.33K | --0 |
Depreciation and amortization | -12.70%163.57K | -9.90%168.84K | -8.82%169.76K | -5.03%746.94K | -8.37%185.99K | -6.00%187.37K | -2.99%187.4K | -2.55%186.19K | 58.27%786.53K | -7.37%202.99K |
Remuneration paid in stock | --0 | ---- | ---- | -78.49%49.59K | --0 | -38.55%49.59K | ---- | ---- | -1.99%230.58K | -75.68%11.53K |
Other non cashItems | 7.65%289.19K | -5.17%243.45K | -0.45%303.86K | -5.30%1.06M | -57.70%225.08K | -27.83%268.63K | 746.71%256.72K | 69.51%305.23K | -44.34%1.11M | -71.43%532.13K |
Change In working capital | -3.46%-420.86K | 18.60%158.95K | 975.23%292.42K | -138.77%-142.56K | 257.16%103.01K | -88.70%-406.79K | 1,373.00%134.03K | -95.75%27.2K | 56.41%367.69K | -153.13%-65.54K |
-Change in receivables | -72.28%9.83K | 72.59%-24.28K | 85.90%-19.15K | -118.94%-194.99K | 87.14%-6.01K | 195.34%35.44K | -1,019.71%-88.6K | -5,010.34%-135.82K | -200.27%-89.06K | -145.26%-46.74K |
-Change in inventory | -22.19%9.51K | 62.91%-5.78K | -110.43%-278 | 106.36%547 | 57.16%1.24K | 588.02%12.22K | -527.41%-15.58K | 125.32%2.67K | -48.94%-8.6K | -14.15%789 |
-Change in prepaid assets | -749.38%-152.22K | -223.30%-19.41K | 59.56%-34.71K | -187.39%-93.03K | -259.29%-46.38K | -48.62%23.44K | 96.87%15.74K | -461.81%-85.84K | -22.21%106.46K | 176.95%29.11K |
-Change in payables and accrued expense | 555.44%222.01K | 142.16%89.21K | 180.31%82.65K | -28.59%151.37K | 372.34%133.79K | -165.78%-48.75K | 201.57%36.84K | -79.78%29.49K | 186.12%211.97K | 151.33%28.33K |
-Change in other working capital | -18.83%-509.98K | -35.78%119.21K | 21.79%263.91K | -104.40%-6.46K | 126.43%20.36K | -45.16%-429.15K | 345.77%185.63K | -54.66%216.7K | -43.77%146.93K | -168.67%-77.03K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 136.04%100.02K | 5.58%67.42K | 92.34%-15.98K | -251.77%-345.95K | 26.74%-243.45K | -87.09%42.38K | 163.95%63.86K | -162.92%-208.74K | 145.82%227.94K | -445.98%-332.29K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -1,283.88%-178.11K | 28.65%-21.71K | 25.96%-28.69K | 93.12%-82.65K | 95.37%-610 | 69.60%-12.87K | 96.85%-30.42K | 78.41%-38.74K | 78.00%-1.2M | -102.43%-13.18K |
Capital expenditure reported | ---- | ---- | ---- | 93.04%-83.65K | ---- | ---- | ---- | ---- | 80.33%-1.2M | 86.91%-13.18K |
Net PPE purchase and sale | -1,283.88%-178.11K | 28.65%-21.71K | 25.96%-28.69K | --1K | --83.04K | ---12.87K | ---30.42K | ---38.74K | --0 | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -1,283.88%-178.11K | 28.65%-21.71K | 25.96%-28.69K | 93.12%-82.65K | 95.37%-610 | 69.60%-12.87K | 96.85%-30.42K | 78.41%-38.74K | 78.00%-1.2M | -102.43%-13.18K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 149.19%448.97K | -85.37%-243.18K | 146.01%87.85K | 28.57%-97.79K | 123.27%44.16K | 152.31%180.17K | -122.87%-131.19K | -8.22%-190.93K | -101.97%-136.9K | 45.90%-189.76K |
Net issuance payments of debt | -53.32%-74.25K | -130.92%-120.78K | 54.80%-46.98K | 16.09%223.78K | 85.96%-14.44K | 52.38%-48.43K | -21.66%390.59K | -2.58%-103.95K | -96.46%192.76K | -2.32%-102.82K |
Net common stock issuance | 82.05%710K | --5K | --285K | --400K | --10K | --390K | --0 | --0 | --0 | --0 |
Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Interest paid (cash flow from financing activities) | -3.99%-157.38K | 75.58%-127.39K | -72.64%-150.17K | -176.50%-911.5K | -74.15%-151.4K | ---151.34K | ---521.78K | -15.84%-86.98K | -21.97%-329.66K | ---86.94K |
Net other financing activities | ---- | ---- | ---- | --189.94K | --200K | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 149.19%448.97K | -85.37%-243.18K | 146.01%87.85K | 28.57%-97.79K | 123.27%44.16K | 152.31%180.17K | -122.87%-131.19K | -8.22%-190.93K | -101.97%-136.9K | 45.90%-189.76K |
Net cash flow | ||||||||||
Beginning cash position | -32.38%301.82K | -8.23%499.28K | -53.58%456.1K | -53.06%982.48K | -56.78%656K | -71.68%446.32K | -73.70%544.07K | -53.06%982.48K | 88.39%2.09M | -22.64%1.52M |
Current changes in cash | 76.88%370.89K | -102.00%-197.46K | 109.85%43.18K | 52.60%-526.38K | 62.65%-199.9K | 459.04%209.68K | 80.16%-97.75K | -1,717.54%-438.41K | -213.08%-1.11M | -508.40%-535.24K |
End cash Position | 2.55%672.71K | -32.38%301.82K | -8.23%499.28K | -53.58%456.1K | -53.58%456.1K | -56.78%656K | -71.68%446.32K | -73.70%544.07K | -53.06%982.48K | -53.06%982.48K |
Free cash from | -373.92%-78.08K | 36.72%45.71K | 81.75%-45.17K | 55.87%-429.6K | 29.36%-244.06K | -90.03%28.51K | 103.14%33.44K | -262.49%-247.48K | 85.26%-973.52K | -113.84%-345.48K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.